MedTrace Logo

Sexuality After Reduction Mammaplasty

NCT01020422 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2019-09-06

No results posted yet for this study

Summary

The aim of this study is to determine the impact of reduction mammaplasty on sexuality and depression predictors in women with macromastia.

Conditions

Interventions

PROCEDURE

Reduction mammaplasty

Sexual function of patients undergoing reduction mammaplasty will be assessed by the Female Sexual Function Index (FSFI) preoperatively and 3 and 6 months postoperatively.

Sponsors & Collaborators

  • Universidade do Vale do Sapucai

    collaborator OTHER

  • Daniela Francescato Veiga

    lead OTHER

Principal Investigators

  • Flavia N Beraldo, PhD · UNIFESP and UNIVAS

  • Daniela F Veiga, MD, PhD · UNIFESP and UNIVAS

  • Lydia M Ferreira, MD, PhD · Federal University of São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2009-11-30
Completion
2011-09-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01020422 on ClinicalTrials.gov